全文获取类型
收费全文 | 46697篇 |
免费 | 3658篇 |
国内免费 | 146篇 |
专业分类
耳鼻咽喉 | 447篇 |
儿科学 | 1334篇 |
妇产科学 | 973篇 |
基础医学 | 6177篇 |
口腔科学 | 685篇 |
临床医学 | 7031篇 |
内科学 | 9396篇 |
皮肤病学 | 754篇 |
神经病学 | 4525篇 |
特种医学 | 1085篇 |
外国民族医学 | 3篇 |
外科学 | 5357篇 |
综合类 | 619篇 |
现状与发展 | 1篇 |
一般理论 | 59篇 |
预防医学 | 5069篇 |
眼科学 | 591篇 |
药学 | 2871篇 |
中国医学 | 87篇 |
肿瘤学 | 3437篇 |
出版年
2023年 | 257篇 |
2022年 | 507篇 |
2021年 | 1032篇 |
2020年 | 682篇 |
2019年 | 1076篇 |
2018年 | 1199篇 |
2017年 | 878篇 |
2016年 | 942篇 |
2015年 | 1106篇 |
2014年 | 1474篇 |
2013年 | 2207篇 |
2012年 | 3338篇 |
2011年 | 3516篇 |
2010年 | 1790篇 |
2009年 | 1702篇 |
2008年 | 3026篇 |
2007年 | 3201篇 |
2006年 | 2958篇 |
2005年 | 2964篇 |
2004年 | 2812篇 |
2003年 | 2504篇 |
2002年 | 2531篇 |
2001年 | 458篇 |
2000年 | 390篇 |
1999年 | 469篇 |
1998年 | 575篇 |
1997年 | 455篇 |
1996年 | 368篇 |
1995年 | 343篇 |
1994年 | 303篇 |
1993年 | 286篇 |
1992年 | 300篇 |
1991年 | 258篇 |
1990年 | 270篇 |
1989年 | 224篇 |
1988年 | 255篇 |
1987年 | 216篇 |
1986年 | 230篇 |
1985年 | 243篇 |
1984年 | 232篇 |
1983年 | 196篇 |
1982年 | 274篇 |
1981年 | 230篇 |
1980年 | 220篇 |
1979年 | 145篇 |
1978年 | 153篇 |
1977年 | 127篇 |
1976年 | 126篇 |
1974年 | 121篇 |
1973年 | 134篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
2.
3.
AbstractGaining a better grasp on factors related to changes in alcohol use is of particular interest for clinicians. Past research has highlighted a negative link between future time perspective (i.e. a disposition guiding how individuals consider and act regarding their future) and alcohol misuse. However, much remains at stake in the understanding of this association. The objective of this research was to explore bidirectional relationships between future time perspective and severity of alcohol-related problems, in a clinical setting. The sample includes 79 patients followed up in an outpatient alcohol treatment centre. Two measurement times were planned: at entry into care and 6 months later. Multiple linear regression analyses were carried out, controlling for sociodemographic variables. We found that baseline future time perspective predicted level of alcohol-related problems after 6 months in treatment, even when effects of baseline alcohol-related problems and sociodemographic variables were controlled. This study shows that the way patients see and position themselves regarding their future can affect level of alcohol-related problems. It may be useful for clinicians to identify patients with low future time perspective to offer tailored interventions and consider this dimension as a resource for change. 相似文献
4.
Claire Letournel François Babinet Bénédicte Allard Vincent Montecot 《Néphrologie & thérapeutique》2019,15(1):51-58
Objective
The “Centre Hospitalier Francois Dunan” is located on an isolated island and ensures patients care in hemodialysis thanks to telemedicine support. Many research studies have demonstrated the importance of hemodialysis fluids composition to reduce morbidity in patients on chronic hemodialysis. The aim of this study was to identify the risks inherent in the production of dialysis fluids in a particular context, in order to set up an improvement action plan to improve risk control on the production of dialysis fluids.Methods
The risk analysis was conducted with the FMECA methodology (Failure Mode, Effects and Criticality Analysis) by a multi professional work group. Three types of risk have been reviewed: technical risks that may impact the production of hemodialysis fluids, health risks linked with chemical composition and health risks due to microbiological contamination of hemodialysis fluids.Results
The work group, in close cooperation with the expert staff of the dialysis center providing telemedicine assistance, has developed an action plan in order to improve the control of the main risks brought to light by the risk analysis.Conclusion
The exhaustive analysis of the risks and their prioritisation have permitted to establish a relevant action plan in this improving quality of dialysis fluids approach. The risk control of dialysis fluids is necessary for the security of dialysis sessions for patients, even more when these sessions are realized by telemedicine in Saint-Pierre-et-Miquelon. 相似文献5.
6.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
7.
8.
9.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 下载免费PDF全文
10.
Margaret H. Lauerman Karen Irizarry Clint Sliker Brandon R. Bruns Ronald Tesoriero Thomas M. Scalea Deborah M. Stein 《Injury》2019,50(1):131-136